{"nct_id":"NCT04895410","title":"Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma","status":"TERMINATED","status_verified_date":"2022-08","start_date":"2022-01-17","start_date_type":"ACTUAL","primary_completion_date":"2022-06-24","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-24","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}